Extraordinary customer experiences from exceptional people, novel solutions, and streamlined operations that prioritize relationships and integrate cutting-edge technologies.
Innovest Global builds long-term shareholder value by acquiring established industrial businesses on favorable terms, realizing synergies and achieving organic growth through investments in innovative technology and business systems.
Today, Innovest Global’s business consists of the following segments:
Commercial Solutions
Provider of best-in-class products and services to commercial and industrial markets.
BioTech Division
Strategic investments in Biotechnology, including the acquisition of a cutting-edge company that develops novel therapies for brain tumor patients.
BioTech division is set for public spin-off into a separate company as early as Q2 2020.